Published Date: 02 Mar 2023
New research has identified hundreds of proteins that can lead to the development of metabolic diseases, such as type 2 diabetes mellitus, and therefore have treatment potential.
Read Full NewsDr Bradley Corr reviews data on the NRG-GY019 and ROSELLA trials, and discusses their clinical impact on ovarian cancer care.
Up to 15 million Americans are at risk of heart failure, with mortality rates rising in the US.
New data show strong links between chronic disease, sexual dysfunction, and loneliness, highlighting missed opportunities for holistic patient evaluation.
The U.S. Supreme Court temporarily reinstated on Monday a federal rule allowing the abortion pill to be prescribed through telemedicine and dispensed through the mail,...
Retirement's a critical window: Boredom, pain, and social withdrawal can push older patients toward alcohol or drugs. Doctors should screen, counsel, and refer to tailored services.
Customizable waveforms in a wearable stimulation device were associated with higher responder rates than standard settings in new research.
Adjunctive cannabidiol improved multiple TSC-associated neuropsychiatric symptoms, including irritability, in a phase 3b/4 study described by investigators as the first to assess these outcomes.
1.
Glofitamab Regimen Improves Survival in DLBCL
2.
Prior authorizations draining time, energy from many cancer patients
3.
The main subject is associated with suicide in the United States.
4.
Drugmaker Pulls Trodelvy's Bladder Cancer Approval
5.
Six breast texture patterns linked to higher risk of invasive cancer
1.
Revolutionizing Cancer Care: The Impact of Darzalex Faspro
2.
Exploring the Mystery of Angiokeratomas on Scrotum: Causes, Symptoms and Treatment
3.
Hemophilia Beyond Boundaries: Unconventional Therapies in Bleeding Disorder Care
4.
Liquid Biopsies and ctDNA: Transforming Cancer Detection, Monitoring, and Clinical Decisions
5.
Tremelimumab: A Potential Breakthrough in Cancer Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III
2.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part II
4.
Efficient Management of First line ALK-rearranged NSCLC - Part VII
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation